• At-Home DNA Testing
  • CES Client Portal

inquiry@psomagen.com

Psomagen
  • Research Sequencing
    • Next Generation Sequencing
      • Whole Genome
      • Exome and Targeted
      • Transcriptome/RNA
      • Metagenome
      • Epigenome Sequencing Services
      • Low Pass Sequencing
      • Bioinformatics Services
    • Single Cell Sequencing
    • Sanger Sequencing
      • Standard Sequencing
      • Custom Sequencing
      • EZ-Seq/EZ-Care
    • Microarray Services
  • Clinical Sequencing
    • Clinical Whole Genome
    • Clinical Whole Exome
  • COVID-19
    • SalivaDirect Diagnostics
    • SalivaDirect™ At-Home Collection Kit
    • Psoma COVID-19 Diagnostics
    • Variant Determination
  • Resources
    • Customer Publications
    • Blog
  • Support
    • NGS Order Guide
    • CES Order Guide
    • Clinical Order Guide
  • About
    • About
    • Investor Information
      • Financial Information
      • Company Announcements
      • Investment Inquiries
    • CLIA/CAP Certification
    • Current Promotions
    • Scholarship
    • Careers
  • Contact Us
  • Menu Menu
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram

Psomagen, Inc.

Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.

Privacy Policy

Terms & Conditions

HIPAA Policy

 

Contact Details

inquiry@nullpsomagen.com
(301) 251-1007

ROCKVILLE, MARYLAND (HQ)
CLIA: 21D2062464  |  CAP: 8742212

BROOKLYN, NEW YORK

CAMBRIDGE, MASSACHUSETTS

STERLING, VIRGINIA
CLIA: 49D2172599

KOSDAQ: PSOMAGEN INC (950200)

© Copyright - Psomagen, Inc. | All sequencing done in the United States | Site Map
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
Scroll to top
25% OFF SEQUENCING

FOR A LIMITED TIME
on HiSeq X™ Systems

Scientist loading HiSeq X System

🧬  $999 per lane 🧬 Results in < 3 weeks 🧬

Samples must arrive by Nov 15, 2021.

Ready to learn more?Talk to an expert